These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8003770)

  • 1. Inhibition of neural and neuroendocrine activity by alpha-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat.
    Saphier D; Roerig SC; Ito C; Vlasak WR; Farrar GE; Broyles JE; Welch JE
    Brain Behav Immun; 1994 Mar; 8(1):37-56. PubMed ID: 8003770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine effects of interferon-alpha in the rat.
    Saphier D
    Adv Exp Med Biol; 1995; 373():209-18. PubMed ID: 7668154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M; Cover PO; Poyser RH; Buckingham JC
    Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-interferon inhibits adrenocortical secretion via mu 1-opioid receptors in the rat.
    Saphier D; Welch JE; Chuluyan HE
    Eur J Pharmacol; 1993 May; 236(2):183-91. PubMed ID: 8391456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis.
    Francis AB; Pace TW; Ginsberg AB; Rubin BA; Spencer RL
    Neuroscience; 2006 Sep; 141(3):1503-15. PubMed ID: 16806720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABA regulates the rat hypothalamic-pituitary-adrenocortical axis via different GABA-A receptor alpha-subtypes.
    Mikkelsen JD; Bundzikova J; Larsen MH; Hansen HH; Kiss A
    Ann N Y Acad Sci; 2008 Dec; 1148():384-92. PubMed ID: 19120132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level.
    Alcaraz C; Vargas ML; Fuente T; Milanés MV
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1602-6. PubMed ID: 8396640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of brain nicotinic acetylcholine receptor in centrally administered corticotropin-releasing factor-induced elevation of plasma corticosterone in rats.
    Okada S; Yamaguchi-Shima N; Shimizu T; Arai J; Lianyi L; Wakiguchi H; Yokotani K
    Eur J Pharmacol; 2008 Jun; 587(1-3):322-9. PubMed ID: 18423439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors.
    Laorden ML; Fuertes G; González-Cuello A; Milanés MV
    J Pharmacol Exp Ther; 2000 May; 293(2):578-84. PubMed ID: 10773031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin-releasing hormone receptors mediate consensus interferon-alpha YM643-induced depression-like behavior in mice.
    Yamano M; Yuki H; Yasuda S; Miyata K
    J Pharmacol Exp Ther; 2000 Jan; 292(1):181-7. PubMed ID: 10604946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced activity of the noradrenergic system in the paraventricular nucleus at the end of pregnancy: implications for stress hyporesponsiveness.
    Douglas AJ; Meddle SL; Toschi N; Bosch OJ; Neumann ID
    J Neuroendocrinol; 2005 Jan; 17(1):40-8. PubMed ID: 15720474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
    Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G
    Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats.
    Naert G; Ixart G; Tapia-Arancibia L; Givalois L
    Neuroscience; 2006 May; 139(2):779-89. PubMed ID: 16457953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons.
    Zelena D; Mergl Z; Makara GB
    Brain Res; 2005 Jan; 1031(2):185-93. PubMed ID: 15649443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute "binge" cocaine on preprodynorphin, preproenkephalin, proopiomelanocortin, and corticotropin-releasing hormone receptor mRNA levels in the striatum and hypothalamic-pituitary-adrenal axis of mu-opioid receptor knockout mice.
    Zhou Y; Spangler R; Schlussman SD; Yuferov VP; Sora I; Ho A; Uhl GR; Kreek MJ
    Synapse; 2002 Sep; 45(4):220-9. PubMed ID: 12125043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    Prather PL; Tsai AW; Law PY
    J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic stimulation of the hypothalamus-pituitary-adrenal axis in rats by interleukin 1beta: central and peripheral mechanisms.
    van der Meer MJ; Sweep CG; Pesman GJ; Tilders FJ; Hermus AR
    Cytokine; 1996 Dec; 8(12):910-9. PubMed ID: 9050749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central stimulation of adrenocortical secretion by 5-hydroxytryptamine1A agonists is mediated by sympathomedullary activation.
    Saphier D; Welch JE
    J Pharmacol Exp Ther; 1994 Sep; 270(3):905-17. PubMed ID: 7932203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal.
    Vining C; Iyer V; Bhatnagar S
    J Neuroendocrinol; 2007 Mar; 19(3):198-207. PubMed ID: 17280593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.